Google Übersetzer
Swedish Orphan Biovitrum Ab
About
Swedish Orphan Biovitrum Ab — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 31 2026
Sobi publishes Annual and Sustainability Report for 2025
Mar 30 2026
EMA validates indication extension application for Tryngolza® (olezarsen) for the treatment of severe hypertriglyceridemia (sHTG)
Mar 27 2026
Notice of Annual General Meeting in Swedish Orphan Biovitrum AB (publ)
Mar 18 2026
Results from EMBRACE Phase 2a study of emapalumab in interferon-gamma-driven sepsis presented at ISICEM
Feb 18 2026
Sobi Capital Markets Day 2026: Bringing brilliant ideas to life and building the next chapter with ambition to deliver SEK 55bn by 2030